The Puzzle of Predicting Response to Immune Checkpoint Blockade

EBioMedicine. 2018 Jul:33:18-19. doi: 10.1016/j.ebiom.2018.06.020. Epub 2018 Jun 20.
No abstract available

MeSH terms

  • Antineoplastic Agents, Immunological / therapeutic use
  • CTLA-4 Antigen / immunology
  • Humans
  • Immunotherapy*
  • Melanoma / immunology
  • Melanoma / therapy
  • Neoplasms / immunology*
  • Neoplasms / therapy
  • Programmed Cell Death 1 Receptor / immunology
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Antineoplastic Agents, Immunological
  • CTLA-4 Antigen
  • Programmed Cell Death 1 Receptor
  • TP53 protein, human
  • Tumor Suppressor Protein p53